ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $448,000 | -7.1% | 91,314 | 0.0% | 0.12% | -10.8% |
Q2 2021 | $482,000 | +10.0% | 91,314 | 0.0% | 0.14% | +9.4% |
Q1 2021 | $438,000 | +10.1% | 91,314 | -0.5% | 0.13% | -4.5% |
Q4 2020 | $398,000 | +4.5% | 91,807 | -0.6% | 0.13% | -7.0% |
Q3 2020 | $381,000 | +60.1% | 92,357 | -0.7% | 0.14% | +45.9% |
Q2 2020 | $238,000 | -10.2% | 92,997 | +1.3% | 0.10% | -26.9% |
Q1 2020 | $265,000 | -23.4% | 91,814 | +0.5% | 0.13% | -3.6% |
Q4 2019 | $346,000 | -43.2% | 91,314 | 0.0% | 0.14% | -44.6% |
Q3 2019 | $609,000 | +7.6% | 91,314 | 0.0% | 0.25% | +5.9% |
Q2 2019 | $566,000 | -12.8% | 91,314 | 0.0% | 0.24% | -9.2% |
Q1 2019 | $649,000 | -16.8% | 91,314 | 0.0% | 0.26% | -18.9% |
Q4 2018 | $780,000 | -25.9% | 91,314 | 0.0% | 0.32% | -25.1% |
Q3 2018 | $1,052,000 | -55.4% | 91,314 | 0.0% | 0.43% | -51.8% |
Q2 2018 | $2,359,000 | +8.1% | 91,314 | 0.0% | 0.89% | +10.7% |
Q1 2018 | $2,182,000 | -33.8% | 91,314 | -6.2% | 0.81% | -32.8% |
Q4 2017 | $3,298,000 | +26.3% | 97,314 | -21.1% | 1.20% | +18.5% |
Q3 2017 | $2,611,000 | +21.0% | 123,314 | 0.0% | 1.01% | +12.6% |
Q2 2017 | $2,157,000 | -0.0% | 123,314 | 0.0% | 0.90% | -3.6% |
Q1 2017 | $2,158,000 | +3.6% | 123,314 | 0.0% | 0.93% | -2.7% |
Q4 2016 | $2,084,000 | +3.0% | 123,314 | 0.0% | 0.96% | +2.1% |
Q3 2016 | $2,024,000 | +8.4% | 123,314 | 0.0% | 0.94% | +4.1% |
Q2 2016 | $1,867,000 | +4.7% | 123,314 | 0.0% | 0.90% | +5.4% |
Q1 2016 | $1,783,000 | – | 123,314 | – | 0.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,601,351 | $43,963,000 | 9.03% |
Granite Point Capital Management, L.P. | 256,031 | $4,327,000 | 3.45% |
Opaleye Management Inc. | 285,000 | $4,817,000 | 2.84% |
Brenner West Capital Advisors | 1,221,463 | $20,643,000 | 2.28% |
ARMISTICE CAPITAL, LLC | 536,000 | $9,058,000 | 2.14% |
NEXTHERA CAPITAL LP | 151,670 | $2,563,000 | 1.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 185,234 | $3,130,000 | 1.41% |
Cheyne Capital Management (UK) LLP | 144,765 | $2,448,000 | 1.38% |
SPHERA FUNDS MANAGEMENT LTD. | 270,000 | $4,563,000 | 1.16% |
Mosaic Family Wealth, LLC | 123,314 | $2,084,000 | 0.96% |